| Nearly one million people in the U.S. and more than six million people worldwide have Parkinson's disease (PD), a ...

Biogen has bought a licence to co-develop and co-market potential Parkinson’s disease drugs with US biotech Denali, in a deal worth more than $2.1 billion. Denali has been working on small ...

"Detecting the earliest signs of Parkinson's disease and establishing the necessary evidence of validity for new measures are critical needs within the healthcare community," said Chris Benko ...

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical ...

Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world's first ...

Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...

A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...

Matthew Moore will bring his play “What I Didn’t Say — a Journey Through Parkinson’s” to Orlando. He wrote the play to “fight back.” ...

John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...

At the Rutgers American Parkinson Disease Association Center for Advanced Research —one of only nine such centers—we don’t just seek to treat the symptoms of Parkinson’s but to cure it. By focusing on ...

Do you get to know whether your kidneys are not working fine? According to experts, five important yet unusual signs point ...